BioCardia Future Growth
Future criteria checks 2/6
BioCardia is forecast to grow earnings and revenue by 26.6% and 68.6% per annum respectively while EPS is expected to grow by 34.6% per annum.
Key information
26.6%
Earnings growth rate
34.6%
EPS growth rate
Biotechs earnings growth | 31.2% |
Revenue growth rate | 68.6% |
Future return on equity | n/a |
Analyst coverage | Low |
Last updated | 11 Nov 2023 |
Recent future growth updates
No updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 6 | -19 | N/A | N/A | 1 |
12/31/2025 | 1 | -19 | N/A | N/A | 1 |
12/31/2024 | 1 | -16 | N/A | N/A | 1 |
12/31/2023 | 0 | -12 | -10 | -10 | N/A |
9/30/2023 | 1 | -13 | -11 | -11 | N/A |
6/30/2023 | 0 | -13 | -11 | -11 | N/A |
3/31/2023 | 1 | -12 | -10 | -10 | N/A |
12/31/2022 | 1 | -12 | -11 | -11 | N/A |
9/30/2022 | 1 | -12 | -11 | -11 | N/A |
6/30/2022 | 2 | -12 | -11 | -11 | N/A |
3/31/2022 | 1 | -13 | -12 | -11 | N/A |
12/31/2021 | 1 | -13 | -10 | -10 | N/A |
9/30/2021 | 1 | -12 | -11 | -11 | N/A |
6/30/2021 | 0 | -13 | -12 | -12 | N/A |
3/31/2021 | 0 | -13 | -11 | -11 | N/A |
12/31/2020 | 0 | -15 | -12 | -12 | N/A |
9/30/2020 | 0 | -16 | -12 | -12 | N/A |
6/30/2020 | 0 | -15 | -10 | -10 | N/A |
3/31/2020 | 1 | -16 | -10 | -10 | N/A |
12/31/2019 | 1 | -15 | -10 | -9 | N/A |
9/30/2019 | 1 | -15 | -10 | -9 | N/A |
6/30/2019 | 0 | -15 | -10 | -10 | N/A |
3/31/2019 | 1 | -14 | -11 | -10 | N/A |
12/31/2018 | 1 | -14 | -11 | -11 | N/A |
9/30/2018 | 1 | -14 | -10 | -10 | N/A |
6/30/2018 | 1 | -13 | -10 | -10 | N/A |
3/31/2018 | 1 | -13 | -10 | -9 | N/A |
12/31/2017 | 0 | -12 | -9 | -9 | N/A |
9/30/2017 | 1 | -12 | N/A | -9 | N/A |
6/30/2017 | 1 | -13 | N/A | -8 | N/A |
3/31/2017 | 1 | -12 | N/A | -7 | N/A |
12/31/2016 | 1 | -10 | N/A | -6 | N/A |
9/30/2016 | 1 | -7 | N/A | -4 | N/A |
6/30/2016 | 1 | -7 | N/A | -5 | N/A |
3/31/2016 | 1 | -6 | N/A | -6 | N/A |
12/31/2015 | 1 | -7 | N/A | -7 | N/A |
3/31/2015 | 1 | -10 | N/A | -6 | N/A |
12/31/2014 | 1 | -10 | N/A | -6 | N/A |
12/31/2013 | 2 | -6 | N/A | -5 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 6JU is forecast to remain unprofitable over the next 3 years.
Earnings vs Market: 6JU is forecast to remain unprofitable over the next 3 years.
High Growth Earnings: 6JU is forecast to remain unprofitable over the next 3 years.
Revenue vs Market: 6JU's revenue (68.6% per year) is forecast to grow faster than the German market (5.2% per year).
High Growth Revenue: 6JU's revenue (68.6% per year) is forecast to grow faster than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: Insufficient data to determine if 6JU's Return on Equity is forecast to be high in 3 years time